New €6 million ophthalmology hospital opens in Alba Iulia
The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.

Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.